Full Text Journal Articles by
Author Warner K Huh

Advertisement

Find full text journal articles






Misoprostol and estradiol to enhance visualization of the transformation zone during cervical cancer screening: An integrative review.

Simon M Manga, Kaitlyn D Kincaid, Teresa K L Boitano, Alan T Tita, Isabel C Scarinci, Warner K Huh, Margaret I Liang,

The purpose of this integrative literature review was to appraise studies conducted worldwide using misoprostol and estradiol in converting Type 3 transformation zone (TZ) of the cervix into Types 1 or 2 and to assess which regimen could be more feasible in low-and-middle-income countries (LMICs). We reviewed the English language ... Read more >>

Eur J Obstet Gynecol Reprod Biol (European journal of obstetrics, gynecology, and reproductive biology)
[2021, 269:16-23]

Cited: 0 times

View full text PDF listing >>



Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer.

Rebecca C Arend, Carly B Scalise, Jhalak Dholakia, Maahum Z Kamal, Haley B Thigpen, David Crossman, Warner K Huh, Charles A Leath,

<h4>Background</h4>Patients with high-intermediate risk endometrial cancer (H-IR EMCA) have an elevated risk of recurrence compared to low-risk counterparts. Many H-IR EMCA patients are treated with radiation or chemotherapy, but their overall survival is not significantly impacted by treatment. The objective of this study was to compare molecular profiles of H-IR ... Read more >>

Cancer Med (Cancer medicine)
[2021, 10(22):8238-8250]

Cited: 1 time

View full text PDF listing >>



Advertisement

Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538].

Kimberly Levinson, Anna L Beavis, Christopher Purdy, Anne F Rositch, Akila Viswanathan, Aaron H Wolfson, Michael G Kelly, Krishnansu S Tewari, Leah McNally, Saketh R Guntupalli, Omar Ragab, Yi-Chun Lee, David S Miller, Warner K Huh, Kelly J Wilkinson, Nicola M Spirtos, Linda Van Le, Yovanni Casablanca, Laura L Holman, Steven E Waggoner, Amanda N Fader,

Gynecol Oncol (Gynecologic oncology)
[2021, 163(3):616-617]

Cited: 0 times

View full text PDF listing >>



Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Rebecca B Perkins, Richard S Guido, Philip E Castle, David Chelmow, Mark H Einstein, Francisco Garcia, Warner K Huh, Jane J Kim, Anna-Barbara Moscicki, Ritu Nayar, Mona Saraiya, George F Sawaya, Nicolas Wentzensen, Mark Schiffman, ,

J Low Genit Tract Dis (Journal of lower genital tract disease)
[2021, 25(4):330-331]

Cited: 0 times

View full text PDF listing >>



Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.

Lari Wenzel, Kathryn Osann, Chelsea McKinney, David Cella, Giulia Fulci, Mary J Scroggins, Heather A Lankes, Victoria Wang, Kenneth P Nephew, George L Maxwell, Samuel C Mok, Thomas P Conrads, Austin Miller, Robert S Mannel, Heidi J Gray, Parviz Hanjani, Warner K Huh, Nick Spirtos, Mario M Leitao, Gretchen Glaser, Sudarshan K Sharma, Alessandro D Santin, Paul Sperduto, Shashikant B Lele, Robert A Burger, Bradley J Monk, Michael Birrer,

<h4>Background</h4>There is a critical need to identify patient characteristics associated with long-term ovarian cancer survival.<h4>Methods</h4>Quality of life (QOL), measured by the Functional Assessment of Cancer Therapy-Ovarian-Trial Outcome Index (FACT-O-TOI), including physical, functional, and ovarian-specific subscales, was compared between long-term survivors (LTS) (8+ years) and short-term survivors (STS) (<5 years) of GOG ... Read more >>

J Natl Cancer Inst (Journal of the National Cancer Institute)
[2021, 113(10):1369-1378]

Cited: 0 times

View full text PDF listing >>



Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study.

Rebecca C Arend, Nidhi Goel, Brandon M Roane, McKenzie E Foxall, Jhalak Dholakia, Angelina I Londoño, Jaclyn A Wall, Charles A Leath, Warner K Huh,

<h4>Background</h4>Both incidence and mortality of uterine cancer are on the rise and mortality is higher for African American women. The aim of our study was to evaluate how Next Generation Sequencing (NGS) may facilitate identification of and intervention for treatment disparities when integrated into clinical workflows.<h4>Results</h4>Our cohort included 159 uterine ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2021, 163(1):85-92]

Cited: 0 times

View full text PDF listing >>



NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.

Nadeem R Abu-Rustum, Catheryn M Yashar, Kristin Bradley, Susana M Campos, Junzo Chino, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Elisabeth Diver, Christine M Fisher, Peter Frederick, David K Gaffney, Suzanne George, Robert Giuntoli, Ernest Han, Brooke Howitt, Warner K Huh, Jayanthi Lea, Andrea Mariani, David Mutch, Larissa Nekhlyudov, Mirna Podoll, Steven W Remmenga, R Kevin Reynolds, Ritu Salani, Rachel Sisodia, Pamela Soliman, Edward Tanner, Stefanie Ueda, Renata Urban, Stephanie L Wethington, Emily Wyse, Kristine Zanotti, Nicole R McMillian, Angela D Motter,

The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas. ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, 19(8):888-895]

Cited: 3 times

View full text PDF listing >>



Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.

Kimberly Levinson, Anna L Beavis, Christopher Purdy, Anne F Rositch, Akila Viswanathan, Aaron H Wolfson, Michael G Kelly, Krishnansu S Tewari, Leah McNally, Saketh R Guntupalli, Omar Ragab, Yi-Chun Lee, David S Miller, Warner K Huh, Kelly J Wilkinson, Nicola M Spirtos, Linda Van Le, Yovanni Casablanca, Laura L Holman, Steven E Waggoner, Amanda N Fader,

<h4>Purpose</h4>The Sedlis criteria define risk factors for recurrence warranting post-hysterectomy radiation for early-stage cervical cancer; however, these factors were defined for squamous cell carcinoma (SCC) at an estimated recurrence risk of ≥30%. Our study evaluates and compares risk factors for recurrence for cervical SCC compared with adenocarcinoma (AC) and develops ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2021, 162(3):532-538]

Cited: 1 time

View full text PDF listing >>



Pathology findings among women with alterations in uterine bleeding patterns in cameroon.

Simon M Manga, Yuanfan Ye, Jeff M Szychowski, Kathleen L Nulah, Calvin Ngalla, Kaitlyn Kincaid, Teresa K L Boitano, Alan T Tita, Isabel Scarinci, Warner K Huh, Zacharie Sando, Margaret I Liang,

<h4>Purpose</h4>Endometrial cancer is on the rise in high-income countries but it has not been adequately studied in low-and-middle income countries especially in sub-Saharan Africa (SSA), likely due to scarce pathology facilities. The purpose of this study was to characterize and quantify the prevalence of endometrial hyperplasia or cancer in a ... Read more >>

Gynecol Oncol Rep (Gynecologic oncology reports)
[2021, 37:100821]

Cited: 0 times

View full text PDF listing >>



A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.

Vicki B Benard, J Elizabeth Jackson, April Greek, Virginia Senkomago, Warner K Huh, Cheryll C Thomas, Lisa C Richardson,

<h4>Background</h4>Despite advances to prevent and detect cervical cancer, national targets for screening have not been met in the United States. Previous studies suggested that approximately half of women who developed cervical cancer were not adequately screened. This study aimed to provide an updated examination of women's screening and diagnostic practices ... Read more >>

Cancer Med (Cancer medicine)
[2021, 10(12):4127-4137]

Cited: 2 times

View full text PDF listing >>



Evaluating meaningful levels of financial toxicity in gynecologic cancers.

Katharine McKinley Esselen, Annika Gompers, Michele R Hacker, Sara Bouberhan, Meghan Shea, Sarah S Summerlin, Lindsay R Rucker, Warner K Huh, Maria Pisu, Margaret I Liang,

<h4>Objective</h4>The Comprehensive Score for Financial Toxicity (COST) is a validated instrument measuring the economic burden experienced by patients with cancer. We evaluated the frequency of financial toxicity at different COST levels and stratified risk factors and associations with cost-coping strategies by financial toxicity severity.<h4>Methods</h4>We analyzed previously collected survey data of ... Read more >>

Int J Gynecol Cancer (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society)
[2021, 31(6):801-806]

Cited: 1 time

View full text PDF listing >>



Measuring Financial Distress and Quality of Life Over Time in Patients With Gynecologic Cancer-Making the Case to Screen Early in the Treatment Course.

Margaret I Liang, Sarah S Summerlin, Christina T Blanchard, Teresa K L Boitano, Warner K Huh, Smita Bhatia, Maria Pisu,

<h4>Purpose</h4>Our objective was to measure the trajectory of financial distress and to determine its relationship with quality of life (QOL) among patients with cancer.<h4>Materials and methods</h4>We conducted a longitudinal survey of patients with gynecologic cancer starting a new line of systemic therapy at baseline, 3 months, and 6 months. Financial ... Read more >>

JCO Oncol Pract (JCO oncology practice)
[2021, 17(10):e1576-e1583]

Cited: 0 times

View full text PDF listing >>



The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?

Whitney N Goldsberry, Sarah S Summerlin, Allison Guyton, Brittani Caddell, Warner K Huh, Kenneth H Kim, Margaret I Liang,

<h4>Objectives</h4>Poly(ADP-ribose) polymerase (PARP) inhibitors are expensive and their use is expanding. We aimed to evaluate cost sharing patterns between patients, payors, and financial assistance programs.<h4>Methods</h4>We identified ovarian cancer patients prescribed a PARP inhibitor from 5/2015-9/2019 using our pharmacy database. Cost information was collected for patients who filled their prescription at ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2021, 160(3):800-804]

Cited: 1 time

View full text PDF listing >>



Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients.

Margaret I Liang, Ling Chen, Dawn L Hershman, Grace C Hillyer, Warner K Huh, Allison Guyton, Jason D Wright,

<h4>Objective</h4>To evaluate total and out-of-pocket costs for poly(ADP-ribose) polymerase (PARP) inhibitors and differences based on insurance characteristics.<h4>Methods</h4>We identified ovarian cancer patients who were prescribed niraparib, olaparib, or rucaparib from the MarketScan (2014-2017) and Surveillance, Epidemiology, and End Results (SEER)-Medicare (2014-2016) databases. Drug costs were estimated for a 30-day supply. Descriptive ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2021, 160(3):793-799]

Cited: 0 times

View full text PDF listing >>



Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Rebecca B Perkins, Richard L Guido, Philip E Castle, David Chelmow, Mark H Einstein, Francisco Garcia, Warner K Huh, Jane J Kim, Anna-Barbara Moscicki, Ritu Nayar, Mona Saraiya, George Sawaya, Nicolas Wentzensen, Mark Schiffman,

J Low Genit Tract Dis (Journal of lower genital tract disease)
[2020, 24(4):426]

Cited: 0 times

View full text PDF listing >>



51st Annual Meeting of the Society of Gynecologic Oncology.

Warner K Huh,

Gynecol Oncol (Gynecologic oncology)
[2020, 159 Suppl 1:1]

Cited: 0 times

View full text PDF listing >>



Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.

Warner K Huh, William E Brady, Paula M Fracasso, Don S Dizon, Matthew A Powell, Bradley J Monk, Charles A Leath, Lisa M Landrum, Edward J Tanner, Erin K Crane, Stefanie Ueda, Michael T McHale, Carol Aghajanian,

<h4>Objective</h4>Women with persistent, recurrent, and/or metastatic cervical cancer have a poor prognosis. Even with the availability of cisplatin plus paclitaxel and bevacizumab, median overall survival (OS) is only 17.0 months, with median post-progression survival of approximately seven months. We studied the therapeutic vaccine, Axalimogene filolisbac (ADXS-HPV), in women who had progressed ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2020, 158(3):562-569]

Cited: 8 times

View full text PDF listing >>



Risk of second primary cancers among survivors of gynecological cancers.

Eric Adjei Boakye, Logan Grubb, Caryn E Peterson, Nosayaba Osazuwa-Peters, Shannon Grabosch, Heather D Ladage, Warner K Huh,

<h4>Objective</h4>Survivors of gynecologic cancers have an increased risk of developing second primary cancers (SPC); however it is unclear which sites have higher risks. We aimed to ascertain risk of SPC among survivors of gynecological cancer, and identify anatomic sites at risk of SPC.<h4>Methods</h4>We queried the Surveillance, Epidemiology and End Results ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2020, 158(3):719-726]

Cited: 1 time

View full text PDF listing >>



Fluorescence Imaging of the Ureter in Minimally Invasive Pelvic Surgery.

Warner K Huh, John L Johnson, Emily Elliott, Jonathan D Boone, Charles A Leath, Joy L Kovar, Kenneth H Kim,

<h4>Study objective</h4>Determine near-optimal dose, safety, and efficacy of nerindocianine in pelvic ureter detection with near-infrared fluorescence imaging in women undergoing minimally invasive pelvic surgery with 3 Food and Drug Administration-cleared imaging systems.<h4>Design</h4>Open label, phase 1/2a study.<h4>Setting</h4>University of Alabama at Birmingham.<h4>Patients</h4>Forty-one female subjects undergoing minimally invasive gynecologic surgery.<h4>Interventions</h4>Subjects received a single ... Read more >>

J Minim Invasive Gynecol (Journal of minimally invasive gynecology)
[2021, 28(2):332-341.e14]

Cited: 1 time

View full text PDF listing >>



Human papillomavirus: The other invisible enemy.

Mary Kathryn Abel, Warner K Huh, John K Chan,

Gynecol Oncol (Gynecologic oncology)
[2020, 158(2):254-255]

Cited: 0 times

View full text PDF listing >>



NCCN Guidelines Insights: Cervical Cancer, Version 1.2020.

Nadeem R Abu-Rustum, Catheryn M Yashar, Sarah Bean, Kristin Bradley, Susana M Campos, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Christine M Fisher, Peter Frederick, David K Gaffney, Robert Giuntoli, Ernest Han, Warner K Huh, John R Lurain Iii, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W Remmenga, R Kevin Reynolds, Rachel Sisodia, Todd Tillmanns, Stefanie Ueda, Renata Urban, Emily Wyse, Nicole R McMillian, Angela D Motter,

The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup, staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and second-line systemic therapy recommendations for patients with recurrent or metastatic disease, and emerging evidence on ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2020, 18(6):660-666]

Cited: 18 times

View full text PDF listing >>



Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil.

Tamy Taianne Suehiro, Gabrielle Marconi Zago Ferreira Damke, Edilson Damke, Paloma Luana Rodrigues de Azevedo Ramos, Marcela de Andrade Pereira Silva, Sandra Marisa Pelloso, Warner K Huh, Ricardo Argemiro Fonseca Franco, Vânia Ramos Sela da Silva, Isabel Cristina Scarinci, Marcia Edilaine Lopes Consolaro,

Background:Despite the demonstrated role of human Papillomavirus (HPV) in the etiology of cervical cancer and the strong evidence suggesting the importance of HPV in the development of oropharyngeal cancer, several aspects of the interrelationship between HPV infection in both body sites remain unknown, specifically in female human immunodeficiency virus (HIV)-positive ... Read more >>

Infect Agent Cancer (Infectious agents and cancer)
[2020, 15:31]

Cited: 2 times

View full text PDF listing >>



The association between social media use for health related information and compliance with breast and cervical cancer screenings.

HyounKyoung G Park, Young-Il Kim, Warner K Huh, Sejong Bae,

There is a need to investigate the impact of social media use on patient compliance with important health screenings due to the inconsistency of research findings on the effect of using social media on cervical cancer screenings. This study assessed associations between social media use and adherence in women at ... Read more >>

Res Rep (Montgomery, Ala.) (Research reports (Montgomery))
[2020, 4:e1-e14]

Cited: 0 times

View full text PDF listing >>



Patterns and Disparities in Human Papillomavirus (HPV) Vaccine Uptake for Young Female Adolescents among U.S. States: NIS-Teen (2008-2016).

Wonsuk Yoo, Alexis Koskan, Matthew Scotch, Heidi Pottinger, Warner K Huh, Deborah Helitzer,

<h4>Background</h4>Several studies have reported differential vaccine uptake outcomes that are associated with sociodemographic and socioeconomic characteristics, as well as provider type. However, none has examined a trend over a multiple-year span. In this study, we utilize a longitudinal data-based approach to examine state-level human papillomavirus (HPV) vaccine trends and their ... Read more >>

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2020, 29(7):1458-1467]

Cited: 1 time

View full text PDF listing >>



2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Rebecca B Perkins, Richard S Guido, Philip E Castle, David Chelmow, Mark H Einstein, Francisco Garcia, Warner K Huh, Jane J Kim, Anna-Barbara Moscicki, Ritu Nayar, Mona Saraiya, George F Sawaya, Nicolas Wentzensen, Mark Schiffman, ,

J Low Genit Tract Dis (Journal of lower genital tract disease)
[2020, 24(2):102-131]

Cited: 71 times

View full text PDF listing >>



Advertisement


Disclaimer

1.3923 s